Demonstrates a synthetic approach to create fused pyrimidine derivatives, indicating potential antibacterial applications.
In this study, we present an efficient and regioselective synthetic approach for the preparation of novel pyrimido[1,6‐ a ]selenopheno[3,2‐ d ]pyrimidine derivatives. The sequence involves the initial condensation of 3‐amino‐2,4‐dicyano‐5‐(pyrrolidin‐1‐yl)selenophene (1) with 5‐bromo‐2,4‐dichloro‐6‐methylpyrimidine (2) , followed by nucleophilic substitution with selected secondary amines. Subsequently, a base‐induced intramolecular cyclization occurring on the nitrile group using NaNH 2 afforded the fused products (6a–f) . Although only a limited number of derivatives were obtained, this sequence offers a straightforward and modular route to fused heterocyclic systems. The structural features, including the disappearance of one nitrile group and the formation of the fused ring system, were characterized by FT‐IR, 1 H NMR, 13 C NMR, HMBC, and 2D NOESY analyses. The obtained data were consistent with the proposed structures and supported the formation of the fused pyrimidine–selenophene framework. This catalyst‐free and operationally simple procedure highlights a practical synthetic pathway to selenium‐containing fused pyrimidines, which have been previously difficult to access. Furthermore, preliminary antibacterial evaluation indicates promising biological potential for the obtained compounds.
No takes yet. Share an insight, caveat, or question.
Mirfarah et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: